Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656135 · ClinicalTrials.gov registry record · Phase 4
Reference Group Trial for The ONE Study
A Phase 4 study, sponsored by University of Regensburg.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT01656135: Completed Phase 4 study, sponsored by University of Regensburg.
NCT01656135 is a Phase 4 study that has completed, run by University of Regensburg. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01656135, a Phase 4 study, has completed, sponsored by University of Regensburg.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
To investigate the progression of the immunological response in living-donor kidney transplant recipients treated with a standard immunosuppressive regimen. Clinical, immunological, and health-economic data collected during this Reference Group Trial will be used to corroborate historical renal transplantation statistics and generate reference ranges for future clinical studies that will test immunoregulatory cell therapy as an adjunct immunosuppressive treatment in renal transplantation.
Interventions
- OTHER Blood drawing for immune monitoring and questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
What the finished NCT01656135 record still lists
NCT01656135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Blood drawing for immune monitoring and questionnaires is the first listed.
NCT01656135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01656135 about?
NCT01656135 is a clinical study titled "Reference Group Trial for The ONE Study". To investigate the progression of the immunological response in living-donor kidney transplant recipients treated with a standard immunosuppressive regimen. Clinical, immunological, and health-economic data collected during this Reference Group Trial will be used to corroborate historical renal tran...
What is the current status of trial NCT01656135?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2012-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01656135?
The interventions under investigation include: Blood drawing for immune monitoring and questionnaires (OTHER).
Who is sponsoring clinical trial NCT01656135?
This trial is sponsored by University of Regensburg, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01656135's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia